KatayounRezvaniMD

PubMed

• 174 citations
  Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unre...
  Antonio Di Stasi, Denái R. Milton, LM Poon, Amir Hamdi, Gabriela Rondon
  Biology of Blood and Marrow Transplantation. 2014-12-01
• 22 citations
  Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Lo...
  Partow Kebriaei, Roland L. Bassett, Genevieve Lyons, Ben C. Valdez, Celina Ledesma
  Biology of Blood and Marrow Transplantation. 2017-02-01
• 1414 citations
  B cells and tertiary lymphoid structures promote immunotherapy response
  Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Basar
  Nature. 2020-01-23

Journal Articles

• Use of CAR-Transduced NK Cells in CD19-Positive Lymphoid Tumors  
  Katayoun Rezvani, MD, The New England Journal of Medicine
• Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy  
  Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
• Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning  
  Yucel OK, Saliba RM, Rondon G, Ahmed S, Alousi A, Bashir Q, Ciurea SO, Popat U, Khouri I, Marin D, Rezvani K, Kebriaei P, Shpall EJ, Champlin RE, Oran B, Cancer, 1/1/2017
• Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia  
  Oran B, Jorgensen JL, Marin D, Wang S, Ahmed S, Alousi AM, Andersson BS, Bashir Q, Bassett R, Lyons G, Chen J, Rezvani K, Popat U, Kebriaei P, Patel K, Rondon G, Shpal..., Haematologica, 1/1/2017
• A subset of virus-specific CD161(+) T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML  
  Alsuliman A, Muftuoglu M, Khoder A, Ahn YO, Basar R, Verneris MR, Muranski P, Barrett AJ, Liu E, Li L, Stringaris K, Armstrong-James D, Shaim H, Kondo K, Imahashi N, A..., Blood, 1/1/2017
• Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma  
  Shah N, Li L, McCarty J, Kaur I, Yvon E, Shaim H, Muftuoglu M, Liu E, Orlowski RZ, Cooper L, Lee D, Parmar S, Cao K, Sobieiski C, Saliba R, Hosing C, Ahmed S, Nieto Y,..., Br J Haematol, 1/1/2017
• Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery  
  Mehta RS, Saliba RM, Cao K, Kaur I, Rezvani K, Chen J, Olson A, Parmar S, Shah N, Marin D, Alousi A, Hosing C, Popat U, Kebriaei P, Champlin R, de Lima M, Skerrett D, ..., Biol Blood Marrow Transplant, 1/1/2017
• Guidelines for the use of flow cytometry and cell sorting in immunological studies  
  Cossarizza A, Chang HD, Radbruch A, Akdis M, Andra I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Bo..., Eur J Immunol, 1/1/2017
• Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease  
  Khoder A, Alsuliman A, Basar R, Sobieski C, Kondo K, Alousi AM, Szydlo R, Muftuoglu M, Shaim H, Apperley JF, Gokdemir E, Cooper N, Mehta RS, Marin D, Champlin R, Shpal..., Front Immunol, 1/1/2017
• Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials  
  Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N, Parmar S, Armitage S, Shpall EJ, Front Med, 1/1/2015
• Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo  
  Parmar S, Liu X, Najjar A, Shah N, Yang H, Yvon E, Rezvani K, McNiece I, Zweidler-McKay P, Miller L, Wolpe S, Blazar BR, Shpall EJ, Blood, 1/1/2015
• Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective  
  Shah N, Rezvani K, Hosing C, Kebriaei P, Wierda W, Cooper L, Shpall E, Clin Lymphoma Myeloma Leuk, 1/1/2014
• Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease  
  Parmar S, Liu X, Tung SS, Robinson SN, Rodriguez G, Cooper LJ, Yang H, Shah N, Yang H, Konopleva M, Molldrem JJ, Garcia-Manero G, Najjar A, Yvon E, McNiece I, Rezvani ..., Cytotherapy, 1/1/2014
• Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity  
  Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, K..., PLoS One, 1/1/2013
• BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress  
  Zou J, Rezvani K, Wang H, Lee KS, Zhang D, Cell Cycle, 1/1/2013
• Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation  
  Chaidos A, Patterson S, Szydlo R, Chaudhry MS, Dazzi F, Kanfer E, McDonald D, Marin D, Milojkovic D, Pavlu J, Davis J, Rahemtulla A, Rezvani K, Goldman J, Roberts I, A..., Blood, 1/1/2012
• BCR-ABL1 kinase domain mutations: methodology and clinical evaluation  
  Alikian M, Gerrard G, Subramanian PG, Mudge K, Foskett P, Khorashad JS, Lim AC, Marin D, Milojkovic D, Reid A, Rezvani K, Goldman J, Apperley J, Foroni L, Am J Hematol, 1/1/2012
• Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in...  
  Mielke S, McIver ZA, Shenoy A, Fellowes V, Khuu H, Stroncek DF, Leitman SF, Childs R, Battiwalla M, Koklanaris E, Haggerty J, Savani BN, Rezvani K, Barrett AJ, Biol Blood Marrow Transplant, 1/1/2011
• Improving outcomes in myeloid leukemia patients: does a new DNA vaccine hold the answer?  
  Rezvani K, de Lavallade H, Expert Rev Vaccines, 1/1/2011
• Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies  
  Rezvani K, Yong AS, Mielke S, Jafarpour B, Savani BN, Le RQ, Eniafe R, Musse L, Boss C, Kurlander R, Barrett AJ, Haematologica, 1/1/2011
• Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies  
  Gerrard G, Mudge K, Stewart R, Foskett P, Stevens D, Khorashad JS, Szydlo R, Rezvani K, Marin D, Reid A, Apperley J, Goldman J, Foroni L, Am J Hematol, 1/1/2011
• Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host  
  de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, Macdonald D, Kelleher P, Cooper N, Khoder A, Gabriel I..., Haematologica, 1/1/2011
• Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib  
  Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvan..., J Clin Oncol, 1/1/2010
• UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors  
  Rezvani K, Teng Y, Pan Y, Dani JA, Lindstrom J, Garc�a Gras EA, McIntosh JM, De Biasi M, J Neurosci, 1/1/2009
• The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib  
  Khorashad JS, Wagner S, Greener L, Marin D, Reid A, Milojkovic D, Patel H, Willimott S, Rezvani K, Gerrard G, Loaiza S, Davis J, Goldman J, Melo J, Apperley J, Foroni L, Haematologica, 1/1/2009
• Join now to see all

Books/Book Chapters

• Advanced Laboratory Methods in Haematology 
  Chapter: ISCH- The Measurement of Serum Vitamin B 12, Serum Folate and Red Cell Folate 
  Wickramasinghe SN, Rezvani K2002

Abstracts/Posters

• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Katy Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Hematopoietic Stem Cell Transplantation
  Rezvani K, Blood; Highlights of ASH in North America, Atlanta, GA, 2017; Seattle, WA, 2017, 1/27/2017
• Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use
  April DePombo, Ana Huertas-Herrera, Mayela Carolina Mendt, Francesca Lorraine Wei Inng Lim, Young Gi, Yijiu Tong, Indreshpal Kaur, May Daher, Rafet Basar, Hila Shaim, ..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Allogeneic Transplantation for TP53+ AML: Prognostic Factors for Survival
  Stefan O. Ciurea, Rima M. Saliba, Julianne Chen, Gabriela Rondon, Uday Popat, Simrit Parmar, Borge Anderson, Amin M. Alousi, Sairah Ahmed, Qaiser Bashir, Gheath Alatra..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Cord Blood NK Cells Engineered to Express a Humanized CD123-Targeted Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia
  Lucila Nassif Kerbauy, Sonny Ang, Enli Liu, Pinaki P Banerjee, Yewen Wu, Hila Shaim, Francesca Lorraine Wei Inng Lim, Rafet Basar, Li Li, Muharrem Muftuoglu, May Daher..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• CS1-Specific Chimeric Antigen Receptor Drives Cord Blood NK Cell Maturation and Expansion In Vivo
  Li Li, Muharrem Muftuoglu, Enli Liu, Sonny Ang, Jiangxing Lv, Xinhai Wan, Rong Cai, Han Chen, Bingqian Hu, Juan Jimenez, Duncan Mak, Jared K Burks, Mustafa H Bdiwi, Pi..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia ...
  Lohith Gowda, Majdi Alijadayeh, David Costa Marin, Celina Ledesma, Gabriela Rondon, Uday Popat, Amin M. Alousi, Betul Oran, Mithun Vinod Shah, Sairah Ahmed, Rashmi Kan..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Evaluation of T Cell Compartment By Mass Cytometry Reveals Distinct Patterns of Expression of Exhaustion Markers in Chronic Lymphocytic Leukemia
  Muharrem Muftuoglu, Li Li, Duncan Mak, Jared K Burks, Yuanxin Xi, Bingqian Hu, Hila Shaim, Nobuhiko Imahashi, Mustafa H Bdiwi, Juan Jimenez, Pinaki P Banerjee, Frances..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Exploring the Cord Blood T Cell Compartment with Mass Cytometry Reveals the Existence of Memory CD4, CD8 and Regulatory T Cell Pools in the Fetal Period
  Muharrem Muftuoglu, Li Li, Juan Jimenez, Duncan Mak, Jared K Burks, Bingqian Hu, Hila Shaim, Nobuhiko Imahashi, Francesca Lorraine Wei Inng Lim, Pinaki P Banerjee, Mus..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival
  Lohith Gowda, Rima M. Saliba, Mithun Vinod Shah, Gabriela Rondon, Irfa Badar, Amanda L. Olson, Stefan O. Ciurea, Partow Kebriaei, Samer A. Srour, Simrit Parmar, Yago N..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies afte...
  Stefan O. Ciurea, Doris Soebbing, Gabriela Rondon, Kai Cao, Gheath Alatrash, Sairah Ahmed, Uday Popat, Betul Oran, Qaiser Bashir, Partow Kebriaei, Indreshpal Kaur, Kat..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Long Term Follow up after Adoptive Transfer of CD19-Specific CAR+ T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell ...
  Partow Kebriaei, Helen Huls, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Elenanor De Groot, Amy Smith, Yijun Yang, Gabriela Rondon, Muzaffar H. Qaz..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• NK Cell Diversity Influences Outcomes after Cord Blood Transplantation
  Li Li, Muharrem Muftuoglu, Han Chen, Duncan Mak, Jared K Burks, Rohtesh S. Mehta, Yuanxin Xi, Jiangxing Lv, Bingqian Hu, Juan Jimenez, Mecit Kaplan, Hila Shaim, Nobuhi..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or P...
  Betul Oran, Guillermo Garcia-Manero, Rima M. Saliba, Gheath Alatrash, Elias J. Jabbour, Uday Popat, Farhad Ravandi, Amin M. Alousi, Tapan Kadia, Marina Konopleva, Cour..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Shortening the Time to Manufacture CAR+ T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19+ Tumors
  Partow Kebriaei, Helen Huls, Susan Lynn Neel, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Amy Smith, Elenanor De Groot, Hagop M. Kantarjian, Maro O..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia
  Betul Oran, Rima M. Saliba, Jeffrey L. Jorgensen, Mithun Vinod Shah, David Costa Marin, Sa A. Wang, Sairah Ahmed, Amin M. Alousi, Borje S Andersson, Qaiser Bashir, Ste..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• The TGF-Beta/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome
  May Daher, Rafet Basar, Hila Shaim, Elif Gokdemir, Nadima Uprety, Alexander Kontoyiannis, Mayela Carolina Mendt, Nobuhiko Imahashi, Lucila Nassif Kerbauy, Francesca Lo..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Can We Make a Better Match Using KIR Genotyping?
  Rezvani K, Blood; American Society of Hematology, San Diego, CA, 1/3/2016
• Join now to see all

Lectures

• Cellular Therapy in Glioblastoma 
  1/1/2018
• CAR-NK Cells: can they compete with CAR-T in immunooncology 
  Berlin, Germany - 1/1/2018
• CAR-T/Cellular Therapy -Clinical Update 
  Salt Lake City, UT - 1/1/2018
• Off-the-shelf CAR-engineered cord blood-derived NK cells for the treatment of cancer � the first-in-human trial 
  Chennai, India - 1/1/2018
• Engineered cord blood NK cells: the first in human trial 
  Lisbon, Portugal - 1/1/2018
• Off-the-shelf CAR-engineered cord blood-derived NK cells for the treatment of cancer- the first-in-human trial 
  San Diego, CA - 1/1/2018
• Immunotherapy: Virus specific lymphocytes for prevention and treatment of Infection 
  Albert Einstein Research and Education Institute, Sao Paulo, Brazil - 1/1/2018
• Cell therapy with CAR T and CAR NK: an alternative treatment 
  Albert Einstein Research and Education Institute, Sao Paulo, Brazil - 1/1/2018
• First-in-human trial of CAR-NK cells 
  Austin, TX - 1/1/2018
• Off-the-shelf engineered NK cells 
  Montreal, Canada - 1/1/2018
• Transforming Medicine with Cell Therapy 
  1/1/2018
• Engineered NK cells for the treatment of cancer 
  Lisbon, Portugal - 1/1/2018
• The FACTs about CARTOX: Immune Effector Cell Therapy Accreditation 
  Salt Lake City, UT - 1/1/2018
• The application of CAR-NK cells for the treatment of cancer 
  University of Leeds, Leeds, United Kingdom - 1/1/2018
• Engineering natural killer cells for cancer immunotherapy 
  Tel Aviv, Israel - 1/1/2018
• NK-CARs - Vive La Difference CLL Global Alliance 
  Houston, TX - 1/1/2018
• Combined CAR-T Congress 
  Berlin, Germany - 1/1/2018
• Cord Blood NK cells to treat cancer 
  Weizmann Institute of Science, Israel - 1/1/2018
• KIR/HLA immunogenetics in allogeneic hematopoietic stem cell transplant 
  Galveston, TX - 1/29/2017
• Post CBT immune interventions 
  Marseille, France - 1/27/2017
• Manufacturing of immune effector cells from umbilical cord products 
  1/26/2017
• CAR-Engineered Cord Blood NK Cells as a Source of Off-the-Shelf Cellular Therapy 
  San Diego, CA - 1/26/2017
• Genetically engineered cord blood NK cells as an of-the-shelf source of immunotherapy for cancer 
  Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2017
• Application of viral specific T cell therapy in transplantation 
  UT MD�Anderson Cancer Center, Houston, TX - 1/1/2017
• Off-the-shelf CAR-engineered cord blood derived NK cells for the treatment of lymphoid malignancies 
  Emory Winship Cancer Institute, Memorial Sloan Kettering Cancer Center, Atlanta, GA - 1/1/2017
• Join now to see all